35 F.4th 854
D.C. Cir.2022Background:
- Plaintiffs (Noah Rosenkrantz, Christopher Thibedeau, and TTEK Inc.) were implicated in an IDB investigation into alleged “Prohibited Practices” (fraud, corruption, collusion, etc.) arising from several IDB‑financed contracts tied to customs systems in Barbados.
- IDB’s Office of Institutional Integrity (OII) investigated, issued Statements of Charges and Evidence, and the Sanctions Officer and Sanctions Committee applied the Bank’s Sanctions Procedures, resulting in multi‑year debarments of the Plaintiffs and related entities.
- The Sanctions Procedures are an internal, multi‑step investigatory and disciplinary regime (investigation by OII, Notice, opportunity to respond, Sanctions Officer decision, appeal to Sanctions Committee); they state they do not alter the IDB’s charter immunities.
- Plaintiffs sued the IDB in U.S. court alleging the Bank breached the Sanctions Procedures, breached an implied duty of good faith, and tortiously interfered with the GreenLine Purchase Agreement by withholding documents and pre‑judging responsibility; they sought injunctive relief and damages.
- The IDB moved to dismiss under Rule 12(b)(1) asserting immunity under the International Organizations Immunities Act (IOIA), which the district court granted; plaintiffs appealed.
Issues:
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether the FSIA/IOIA commercial‑activity exception (28 U.S.C. §1605(a)(2)) permits suit | Gravamen is breach of contractual duties tied to IDB‑financed contracts (commercial activity); contracts or solicitation form a necessary element | Gravamen is IDB’s internal application of its Sanctions Procedures (sovereign/administrative action), not commercial activity | Court: Gravamen is enforcement of Sanctions Procedures (sovereign‑style power); commercial‑activity exception does not apply |
| Whether Article XI §3 of the IDB Charter waived immunity (IOIA waiver exception) | Charter’s venue/waiver language broadly permits suit; judicial review would reassure commercial partners and aid IDB’s objectives | Prior precedent (Mendaro/Atkinson) requires a corresponding‑benefit balancing test; judicial scrutiny of internal sanctions would burden IDB’s charter functions | Court: Under the corresponding‑benefit test, benefits of waiver are outweighed by burdens (risk of fragmented litigation/delays); no waiver |
Key Cases Cited
- Jam v. Int’l Fin. Corp., 139 S. Ct. 759 (2019) (IOIA immunity is coextensive with FSIA foreign sovereign immunity)
- OBB Personenverkehr AG v. Sachs, 577 U.S. 27 (2015) (identify gravamen of suit; reject single‑element test)
- Saudi Arabia v. Nelson, 507 U.S. 349 (1993) (commercial‑activity analysis and gravamen framing)
- Republic of Argentina v. Weltover, Inc., 504 U.S. 607 (1992) (distinguishing sovereign acts from commercial acts)
- Mwani v. bin Laden, 417 F.3d 1 (D.C. Cir. 2005) (commercial character determined by behavior, not motive)
- Mendaro v. World Bank, 717 F.2d 610 (D.C. Cir. 1983) (corresponding‑benefit test for charter waiver of immunity)
- Atkinson v. Inter‑Am. Dev. Bank, 156 F.3d 1335 (D.C. Cir. 1998) (applies Mendaro’s narrower waiver analysis to IDB charter)
- Lutcher S.A. Celulose e Papel v. Inter‑Am. Dev. Bank, 382 F.2d 454 (D.C. Cir. 1967) (earlier broad reading of Article XI §3 waiver; discussed but limited by later precedent)
- Vila v. Inter‑Am. Inv. Corp., 570 F.3d 274 (D.C. Cir. 2009) (waiver analysis in the context of enhancing marketability/credibility)
- Odhiambo v. Republic of Kenya, 764 F.3d 31 (D.C. Cir. 2014) (earlier endorsement of single‑element approach; superseded by Sachs)